Format

Send to

Choose Destination
Int J Tuberc Lung Dis. 2013 Dec;17(12):1575-80. doi: 10.5588/ijtld.13.0144.

Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China.

Author information

1
Department of Tuberculosis, Third Hospital of Zhenjiang City, Zhenjiang, People's Republic of China; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.

Abstract

SETTING:

A county in Jiangsu Province, China.

OBJECTIVES:

To estimate the costs of the diagnosis and treatment of tuberculosis (TB) from the patient's perspective and to identify determinants of the patient's financial burden.

DESIGN:

In a cross-sectional survey, we interviewed 316 patients diagnosed from January 2010 to May 2011 who had already completed their anti-tuberculosis treatment. The financial burden on TB patients included out-of-pocket costs and productivity losses.

RESULTS:

The average per capita total out-of-pocket cost was 3024.0 Chinese yuan (CNY), with a median cost of 1086 CNY (interquartile range [IQR] 480-2456). Mean out-of-pocket medical and non-medical costs were respectively 2565.7 CNY and 458.3 CNY. Productivity lost by patients and family members was 2615.2 CNY (median 500, IQR 250-2025). Factors associated with out-of-pocket costs and productivity losses included hospitalisation, adverse drug reactions, cost of drugs to 'protect' the liver, cost of second-line anti-tuberculosis drugs and diagnostic delay.

CONCLUSION:

Although the government of China has implemented a 'free TB service policy', the economic burden on patients is still heavy. More patient-centred interventions are essential to reduce the financial burden on patients.

PMID:
24200271
DOI:
10.5588/ijtld.13.0144
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ingenta plc
Loading ...
Support Center